Kalamazoo, MI, United States of America

Jason K Myers


Average Co-Inventor Count = 5.1

ph-index = 9

Forward Citations = 231(Granted Patents)


Company Filing History:


Years Active: 2002-2006

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jason K. Myers

Introduction

Jason K. Myers is a prominent inventor based in Kalamazoo, MI (US), known for his significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, Myers has made remarkable strides in developing compounds that have the potential to treat various diseases.

Latest Patents

Among his latest patents, Myers has developed azabicyclic compounds for the treatment of disease. These compounds are characterized by a six-membered heterocyclic ring system that contains 1–2 nitrogen atoms or a 10-membered bicyclic-six-six-fused-ring system with up to two nitrogen atoms. The invention also includes pharmaceutical salts or compositions that may be in pure enantiomeric form or racemic mixtures, which are useful in treating diseases where α7 is known to be involved. Another notable patent involves azabicyclic-substituted-heteroaryl compounds, which also serve a similar purpose in pharmaceuticals.

Career Highlights

Throughout his career, Jason K. Myers has worked with esteemed companies such as Pharmacia & Upjohn Company and Pfizer Corporation. His experience in these organizations has greatly contributed to his expertise in pharmaceutical innovations.

Collaborations

Myers has collaborated with notable colleagues, including Vincent E. Groppi, Jr. and David W. Piotrowski. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the pharmaceutical industry.

Conclusion

Jason K. Myers exemplifies the spirit of innovation in the pharmaceutical field through his extensive patent portfolio and collaborative efforts. His work continues to pave the way for advancements in treatments for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…